The most common ethical failure in psychedelic support work is not malice. It is scope creep. An integration coach starts the relationship inside their lane, gradually accepts responsibility for material that requires a licensed clinician, and ends up holding a case they were never trained to manage. A therapist takes on a client whose primary support need is acute-phase containment during dosing, and offers integration framing they have no training in. A trip sitter who held a strong dosing experience is asked to continue the work weeks later, and agrees because the relationship feels mature. Across 900-plus integration sessions, including consults with practitioners trying to clean up boundary violations after the fact, the pattern is consistent. The problem started with a title that did not match the role being performed.
The Marks et al., JAMA Network Open 2024 ethics and policy framework was the first multi-stakeholder consensus to define these roles after the FDA Complete Response Letter on Lykos Therapeutics' MDMA-PTSD application reframed the regulatory landscape. The Pilecki 2021 Harm Reduction Journal paper, DOI 10.1186/s12954-021-00489-1, laid the earlier ethical foundation. The MAPS Code of Ethics enumerates the 12 principles that serious practitioners treat as the working baseline. Together these sources draw the lines this article maps.
For deeper coverage of the work itself across each role, see what happens in an integration session, when not to do psychedelics, the psychedelic afterglow window, psychedelics and decision-making, and psychedelics and high-functioning depression.
- The Marks et al., JAMA Network Open 2024 paper was the first multi-stakeholder ethics consensus published after the FDA Complete Response Letter on Lykos MDMA-PTSD reset the regulatory landscape.
- Integration coaches operate outside licensure, cannot diagnose, cannot bill insurance, and cannot legally provide controlled substances. Their scope is meaning-making, behavior change, and applying session content to daily life.
- Licensed therapists can diagnose and treat mental health conditions but in most jurisdictions cannot provide psychedelic substances outside of FDA-approved trials, Oregon Measure 109, Colorado Proposition 122, or comparable frameworks.
- The MAPS Code of Ethics enumerates 12 principles, with the touch, sexual contact, and financial transparency principles being the most rigorously enforced because they correspond to documented patterns of practitioner harm.
- Heightened suggestibility during and after dosing is the most underweighted ethics issue. The Pilecki 2021 paper identifies it as the central informed-consent risk that distinguishes psychedelic work from conventional therapy.
- The 2024 scoping review PMC12527517 found that conflating sitter, coach, and therapist roles is a primary source of harm. The three roles require different training and should not be casually merged.
Why Does Scope of Practice Matter in Psychedelic Work?
Scope of practice matters because psychedelic sessions surface material that exceeds the competence of most generalist support providers, and the post-session window concentrates risk in ways conventional therapy and conventional coaching do not anticipate. The Pilecki 2021 paper in Harm Reduction Journal frames this directly. The combination of heightened suggestibility, altered self-boundaries, and concentrated trust in the practitioner creates an ethical loading the rest of the support professions are not calibrated to.
A licensed therapist working within their scope is trained to recognize when a case exceeds their competence and refer out. The licensing system enforces this through liability, supervision, and continuing education. An unlicensed integration coach operating in the same space has no comparable enforcement mechanism. The discipline has to come from the coach's own training, supervision practice, and willingness to refuse cases. In practice, refusal is the harder discipline.
The reframe that matters here is that scope is not about hierarchy. A coach is not a junior therapist. A therapist is not a senior coach. They occupy different roles, with different training, different legal status, and different ethical obligations. Mapping which role is appropriate for a specific person at a specific moment is the first job. Doing the work that role allows is the second job. Confusing the two is the source of the harm patterns that the 2024 scoping review PMC12527517 catalogs.
According to Pilecki and colleagues in 2021, writing in Harm Reduction Journal under DOI 10.1186/s12954-021-00489-1, the ethical challenges of psychedelic support work differ structurally from those of conventional psychotherapy in three respects. First, the heightened suggestibility of participants during and after dosing concentrates the informed-consent burden in ways that standard therapeutic frameworks were not designed to absorb. Second, the trust gradient between practitioner and participant is steeper, which amplifies the harm potential of dual relationships and boundary blurring. Third, the post-session integration window creates a plasticity period in which the participant is unusually open to influence, and any practitioner operating in this window inherits an asymmetric ethical responsibility regardless of their licensure status. The clinical implication is that the standard scope-of-practice framework from conventional therapy is necessary but not sufficient for psychedelic work, and additional discipline around touch, financial transparency, and post-session boundary management is required.
What Are the Three Roles in Psychedelic Support Work?
The three primary roles in psychedelic support work are the licensed therapist, the integration coach, and the trip sitter, and each has a different training profile, legal status, and scope of practice. The 2024 scoping review published as PMC12527517 catalogs how casually these roles are merged in non-clinical contexts, and identifies the merging as a primary harm vector. Treating the three as distinct functions, even when one person performs more than one of them, is the working baseline.
The Licensed Therapist
A licensed therapist is a clinician regulated by a state or national licensing body. The credentialing varies across psychologists, psychiatrists, licensed clinical social workers, marriage and family therapists, and licensed mental health counselors. The common features are the right to diagnose under DSM-5 or ICD-11 criteria, the ability to bill insurance in many jurisdictions, mandated reporting obligations, and a defined scope-of-practice constraint enforced by the licensing board.
In most jurisdictions in 2026, a licensed therapist cannot legally provide psychedelic substances outside of FDA-approved trials, Oregon Measure 109 service-center contexts, Colorado Proposition 122 frameworks, ketamine-assisted psychotherapy with appropriate prescriber relationships, or comparable regulated environments. The therapy itself is legal everywhere. The substance provision is not.
The Integration Coach
An integration coach is an unlicensed practitioner who specializes in the post-session work of metabolizing psychedelic experiences into durable behavior change. The role does not require licensure because it does not involve diagnosis or treatment of mental health conditions as conditions. The scope is meaning-making, application of session content, behavior change support, decision architecture, and the slow translation of altered-state insight into ordinary-state structure.
The honest framing is that coaching is appropriate for participants who do not have a diagnosable mental health condition driving their work, or who have such a condition but are receiving qualified clinical care separately. Coaches who work with diagnosed populations as the primary support relationship are operating outside scope, regardless of how skilled they are.
The Trip Sitter
A trip sitter holds physical safety during the acute phase of a session. The role is hours-long, focused on the dosing window itself, and involves minimal verbal intervention. Sitting is not integration. The skill set is overlapping but distinct. Many sitters are not trained for integration, and many integration practitioners are not qualified to manage acute medical or psychiatric events during dosing. Conflating the two roles is a documented source of harm in the 2024 scoping review.
What Does the MAPS Code of Ethics Actually Require?
The MAPS Code of Ethics enumerates 12 principles that serious practitioners treat as the working ethical baseline regardless of legal status, and the touch, sexual contact, and financial transparency principles are the most rigorously enforced because they correspond to documented patterns of harm. The code is not a license. It is an internal field standard developed across decades of clinical and underground practice, and adopted by most reputable training programs as the operating contract.
The Touch Principle
Touch is permitted only with explicit prior consent established outside of the dosing window, documented in writing, and limited to specific forms agreed to in advance. The heightened suggestibility of the dosing state means that consent given during dosing is not a clean consent. Touch during dosing is a high-risk action even when well-intentioned. The conservative practice is minimal touch, prior consent, and clear withdrawal mechanics. Most practitioner harm cases in the literature involve touch escalation that the participant could not effectively decline in the altered state.
The Sexual Contact Prohibition
Sexual contact between practitioner and participant is prohibited categorically. The prohibition extends past the formal end of the practitioner relationship for a duration that varies across codes but is typically multi-year and often lifelong. The reasoning is that the trust gradient and the suggestibility loading do not dissipate at the moment a session ends. Participants who later enter sexual relationships with former practitioners are often retrospectively distressed in ways that take years to surface.
Financial Transparency
Financial transparency means clear pricing disclosed in advance, no contingent fees tied to session outcomes, no upselling during the suggestibility window, no investment solicitations, and no business partnerships with former participants for a defined post-relationship period. The financial principle is the third most violated in the documented cases because the heightened-suggestibility window is also a high-decision-receptivity window, and financial decisions made in this state are uniquely vulnerable.
"The cleanest practitioner I have worked alongside has a simple rule. No business conversations of any kind, including her own pricing, during the 30-day window after a session. If a participant wants to extend the engagement, the conversation waits until day 31. That rule alone removes most of the financial harm vector the field actually struggles with."
The MAPS Code of Ethics enumerates 12 principles covering informed consent before dosing, the explicit limits of practitioner scope, the prohibition of dual relationships, confidentiality with defined exceptions for mandated reporting, financial transparency including disclosure of all fees in advance, the categorical prohibition of sexual contact during and after the practitioner relationship, the handling of touch with explicit prior written consent, the management of heightened suggestibility across dosing and integration windows, ongoing peer supervision, continued professional education, conflict-of-interest disclosure, and the affirmative duty to refer cases that exceed practitioner competence. The touch, sexual, and financial principles are the three most rigorously enforced because they correspond to the documented patterns of practitioner harm that have surfaced in field reports across the past decade. The principles function as the working baseline for serious practitioners regardless of whether they hold formal licensure.
What Did the 2024 JAMA Network Open Consensus Establish?
The Marks et al., JAMA Network Open 2024 paper was the first multi-stakeholder ethics and policy framework published after the FDA Complete Response Letter on Lykos Therapeutics' MDMA-PTSD application, and it shifted the conversation from clinical-trial ethics to field-wide scope-of-practice ethics. The consensus brought together clinicians, ethicists, regulators, and lived-experience representatives to define minimum standards for the practitioner roles that will outlive the regulatory pathway uncertainty.
The Diagnostic Boundary
The JAMA consensus reinforced that diagnosis is a licensed activity. Unlicensed practitioners, including integration coaches, cannot diagnose mental health conditions, cannot tell a participant they have PTSD or depression as a clinical determination, and cannot treat such conditions as conditions. They can describe what they observe, recommend evaluation by a licensed clinician, and support a participant who is also working with one. The line is bright and the consequence of crossing it is both ethical and legal.
The Concurrent Care Requirement
For participants with diagnosed mental health conditions, the JAMA framework recommends concurrent qualified clinical care as a precondition for non-clinical psychedelic support. An integration coach working with someone who has bipolar disorder, severe PTSD, or major depression should require the participant to maintain an active relationship with a licensed clinician. If that relationship is not in place, the coach should refer rather than take on the case as the primary support.
The Heightened Suggestibility Acknowledgment
The consensus explicitly named heightened suggestibility as the ethics issue that distinguishes psychedelic work from conventional therapy. The standard informed-consent frameworks from conventional clinical practice were designed for ordinary cognitive states. Psychedelic dosing and the post-session window are not ordinary states. Consent for substantive decisions, financial commitments, relational changes, and even integration practice intensification needs to be re-anchored in ordinary-state cognition before it is acted on.
The Referral Duty
The consensus framed referral as an affirmative duty, not a defensive option. Practitioners are expected to maintain a referral list, recognize when a case exceeds competence, and refer proactively rather than expand scope to retain the client. The financial and ego incentives both push against referral. The discipline of referring early is what separates ethically careful practitioners from operators.
Why Is Heightened Suggestibility the Central Ethics Issue?
Heightened suggestibility during and after dosing concentrates the informed-consent burden in ways that conventional therapy ethics frameworks were not designed to absorb, and the Pilecki 2021 Harm Reduction Journal paper identifies it as the distinguishing ethical feature of psychedelic practitioner work. Ordinary therapy assumes the client is capable of informed consent in roughly ordinary cognitive states. Psychedelic work cannot make that assumption during dosing, and only with caveats in the days and weeks after.
What Heightened Suggestibility Looks Like
During dosing, the participant's ordinary skepticism, self-protective filtering, and capacity to disagree with the practitioner are meaningfully reduced. Suggestions land with disproportionate weight. Statements that would be examined in an ordinary state are absorbed with minimal scrutiny. After dosing, the open plasticity window persists for days to weeks, and the participant remains more receptive to practitioner framing than they would be at baseline.
Why This Reshapes Consent
Consent given during or shortly after dosing for substantive decisions is not clean consent. The conservative practice is to defer all substantive decisions, including business arrangements, fee changes, relationship continuation, and intensification of work, until the participant has returned to ordinary cognitive states and reviewed the decision from there. The 30-day post-session window is the conservative threshold I use in my own practice.
The Practical Test
A useful working test is whether the participant could give the same consent in a coffee shop two months later, with no prior framing, after sleeping on it. If the answer is yes, the consent is clean enough to act on. If the answer is uncertain, the action should wait. This test is unflattering to practitioners who depend on suggestibility-window decisions to maintain their pipeline. The test exists for that reason.
According to the 2024 scoping review by Penn and colleagues, published as PMC12527517 and covering peer-reviewed literature on psychedelic practitioner ethics from 2010 through 2024, the conflation of sitter, integration coach, and licensed therapist roles is the single most common structural source of harm in non-clinical psychedelic contexts. The review found that practitioner harm reports clustered around three vectors. First, sitters who extended into integration work without integration training. Second, coaches who took on diagnosed populations as the primary support relationship without concurrent clinical care. Third, practitioners who used the heightened-suggestibility window to expand scope, change financial terms, or initiate dual relationships. The clinical implication is that role clarity, written informed consent, and active referral discipline are not bureaucratic overhead. They are the operational infrastructure that prevents the harm patterns the literature now identifies.
How Do You Choose Between Coach, Therapist, and Sitter?
The decision turns on whether you have a diagnosed mental health condition driving the work, whether you have qualified clinical care in place, and which phase of the arc you need support in. The checklist below organizes the screening questions that should be answered before any engagement is committed to. The honest answer to these questions determines which role is appropriate, and a practitioner who declines you when the answer doesn't match their role is doing the work correctly.
Does any of the following describe your situation?
- You have a diagnosed mental health condition without active concurrent care
- You suspect you may have an undiagnosed condition that needs evaluation
- You are in active psychiatric crisis or acute trauma phase
- You need a provider who can bill insurance for your work
- You need diagnosis, formal treatment planning, or medication coordination
- You are considering ketamine-assisted therapy or a regulated psilocybin service center
- Your work involves complex trauma requiring trauma-specialist training
Does any of the following describe your situation?
- You do not have a diagnosed mental health condition driving the work
- You have qualified clinical care already in place and want adjunctive integration support
- You are focused on meaning-making, behavior change, or applying session content to daily life
- Your goals are decision architecture, relational integration, or work and life-structure changes
- You have completed your session in a regulated or otherwise safe context
- You want a practitioner with depth in the integration phase specifically
- You can articulate clear outcomes you are working toward across a defined engagement window
What to Ask Any Practitioner Before Committing
The screening conversation should establish role, scope, ethics framework, supervision practice, referral patterns, and financial terms. The questions below are the practical ones. A practitioner who cannot answer them clearly is not ready to hold the work.
- What is your specific role here, and what falls outside it?
- What licensure or training do you hold, and what does it allow you to do?
- What ethics code do you operate under, and who supervises your work?
- What is your referral practice when a case exceeds your scope?
- What are your financial terms, and when in the arc do we agree to them?
- How do you handle the post-session suggestibility window?
- What is your policy on touch, and how is consent established?